IRCT20171015036782N9招募中3 期
The effect of resveratrol supplementation on clinical parameters and inflammatory markers in diabetic patients with chronic periodontitis
Yazd University of Medical Sciences0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 60 years（—）
- 性别
- All
入选标准
- •Age between 30-60 years
- •Body mass index (BMI) 18.5 to 30 kg/m2
- •Patients with confirmed and controlled diabetes mellitus (minimum one year and maximum 5 years since diagnosis)
- •Moderate to severe periodontal disease
排除标准
- •Patient non-cooperation
- •Diabetes complications such as kidney failure
- •No systemic disease
- •taking medication
- •Pregnancy and breastfeeding
- •Allergy to black grapes or blueberries
研究者
相似试验
已完成
2 期
Evaluation of the effects of Resveratrol Supplementation on Hepatic Enzymes, Inflammatory Factors, Lipid profile, blood glucose, Insulin Sensitivity, and Hepatic fibrosis in patients with Nonalcoholic Fatty Liver Disease.on Alcoholic Fatty Liver.Inflammatory liver disease, unspecifiedIRCT201202014010N7ational Nutrition and Food Technology Research Institute50
尚未招募
不适用
Effect of Sublingual Supplementation with Resveratrol in patients with Renal DiseaseHemodialysisInflammationOxidative stress.N18.0Chronic Kidney DiseaseE02.870.300C23.550.470G03.673RBR-43mg87niversidade do Sul de Santa Catarina
招募中
3 期
Resveratrol in multiple sclerosisMultiple sclerosisMultiple Sclerosis.IRCT20230315057731N1Ahvaz University of Medical Sciences60
已完成
3 期
Evaluation of the effects of resveratrol in patients with Covid ??Covid-19.COVID-19, virus identifiedIRCT20111119008129N13Boushehr University of Medical Sciences140
招募中
不适用
Effect of herbal medicine, Resveratrol, on gingival infectioIRCT20171015036782N6Yazd University of Medical Sciences40